Contact

• workRoom E209 Biodiscovery Institute 3
  University Park
  Nottingham
  NG7 2RD
  UK
• Jason.Adhikaree2@nottingham.ac.uk

Biography

I graduated from Imperial College London in 2008 with MBBS and BSc (Hons) in Neuroscience. I completed my junior doctor training in London and East Midlands. I've previous held NIHR Academic Clinical Fellowship from ST3 and subsequently a MRC Clinical research training fellowship, completing my PhD in 2019. I am an Honorary Consultant Medical Oncologist at Nottingham University Hospitals and a Clinical Associate Professor at the University of Nottingham.

Expertise Summary

My PhD focused on dendritic cells dysfunction in cancer, specifically Glioblastoma and mechanism to reverse immune suppression. I am Principal Investigator on a number of Lung cancer interventional trials.

Teaching Summary

I currently lecture on the MSc Oncology course and Cancer Sciences BSc. I am also a module convenor on the Cancer Sciences BSc, supervise BMedSci students and undergraduate Medical students.

Research Summary

My main research interests include immune dysfunction in cancer and discovery and delivery of new treatments for cancer

Recent Publications

• RASQUINHA M and ADHIKAREE J, 2023. A Rapidly Enlarging Skin Lump. Cureus.
• PEARSON JRD, CUZZUBBO S, MCARTHUR S, DURRANT LG, ADHIKAREE J, TINSLEY CJ, POCKLEY AG and MCARDLE SEB, 2020. Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment. Frontiers in immunology.
• ADHIKAREE J, MORENO-VICENTE J, KAUR AP, JACKSON AM and PATEL PM, 2020. Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma. Cells.
• ADHIKAREE J, FRANKS HA, TELEVANTOS C, VAGHELA P, KAUR AP, WALKER D, SCHMITZ M, JACKSON AM and PATEL PM, 2019. Impaired circulating myeloid CD1c+ dendritic cell function in human glioblastoma is restored by p38 inhibition - implications for the next generation of DC vaccines. Oncoimmunology.

• View all publications

• RASQUINHA M and ADHIKAREE J, 2023. A Rapidly Enlarging Skin Lump. Cureus.
• PEARSON JRD, CUZZUBBO S, MCARTHUR S, DURRANT LG, ADHIKAREE J, TINSLEY CJ, POCKLEY AG and MCARDLE SEB, 2020. Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment. Frontiers in immunology.
• ADHIKAREE J, MORENO-VICENTE J, KAUR AP, JACKSON AM and PATEL PM, 2020. Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma. Cells.
• ADHIKAREE J, FRANKS HA, TELEVANTOS C, VAGHELA P, KAUR AP, WALKER D, SCHMITZ M, JACKSON AM and PATEL PM, 2019. Impaired circulating myeloid CD1c+ dendritic cell function in human glioblastoma is restored by p38 inhibition - implications for the next generation of DC vaccines. Oncoimmunology.
• SAVVA C, ADHIKAREE J, MADHUSUDAN S and CHOKKALINGAM K, 2019. Oncogenic osteomalacia and metastatic breast cancer: a case report and review of the literature. Journal of diabetes and metabolic disorders.
• ADHIKAREE J, NEWBY Y and SUNDAR S, 2015. RE: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment. Journal of the National Cancer Institute.
• ADHIKAREE J, NEWBY Y and SUNDAR S, 2014. Denosumab should be the treatment of choice for bisphosphonate refractory hypercalcaemia of malignancy. BMJ case reports.
• ADHIKAREE J and MADHUSUDAN S, 2014. Is there a role for second-line platinum re-challenge in advanced biliary tract cancers? Medical oncology (Northwood, London, England).
• CHEN HJ, ANAGNOSTOU G, CHAI A, WITHERS J, MORRIS A, ADHIKAREE J, PENNETTA G and DE BELLEROCHE JS, 2010. Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. The Journal of biological chemistry.